Human Protein Engineered to Capture Circulating Tumor Cells

04:44 EDT 29 Jun 2017 | Genetic Engineering News

Scientists at the Wyss Institute at Harvard University have engineered the human blood opsonin protein known as FcMBL, which was originally developed as a broad-spectrum pathogen capture agent, to target circulating tumor cells (CTCs) instead. The team reportedly used magnetic beads coated with FcMBL to capture 90% of seven different types of cancer cells. The novel approach could become useful in cancer diagnostics, according to the investigators. “The FcMBL capture technology may therefore provide a new tool for harvesting a broad range of CTCs with high efficiency as it targets tumor cell specific surface markers that are expressed across diverse cell types and retained throughout the metastatic process,” write the researchers  in a paper (“An Engineered Human Fc-Mannose-Binding-Lectin Captures Circulating Tumor Cells”) that appears in Advanced Biosystems. "We were able to rapidly isolate CTCs both in vitro and from blood, including some which are not bound ...

Original Article: Human Protein Engineered to Capture Circulating Tumor Cells


More From BioPortfolio on "Human Protein Engineered to Capture Circulating Tumor Cells"

Quick Search


Relevant Topics

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...